CVA Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
2,782
-123
| -4% | -$95.9K | 0.3% | 58 |
|
|
2025
Q1 | $2.4M | Buy |
2,905
+192
| +7% | +$159K | 0.37% | 54 |
|
|
2024
Q4 | $2.09M | Buy |
2,713
+104
| +4% | +$80.3K | 0.33% | 57 |
|
|
2024
Q3 | $2.31M | Buy |
2,609
+60
| +2% | +$53.2K | 0.38% | 52 |
|
|
2024
Q2 | $2.31M | Buy |
2,549
+33
| +1% | +$29.9K | 0.42% | 44 |
|
|
2024
Q1 | $1.96M | Buy |
2,516
+6
| +0.2% | +$4.67K | 0.35% | 50 |
|
|
2023
Q4 | $1.46M | Hold |
2,510
| – | – | 0.29% | 55 |
|
|
2023
Q3 | $1.35M | Buy |
2,510
+92
| +4% | +$49.4K | 0.31% | 60 |
|
|
2023
Q2 | $1.13M | Buy |
2,418
+88
| +4% | +$41.3K | 0.24% | 72 |
|
|
2023
Q1 | $800K | Sell |
2,330
-241
| -9% | -$82.8K | 0.18% | 84 |
|
|
2022
Q4 | $941K | Buy |
2,571
+166
| +7% | +$60.7K | 0.23% | 71 |
|
|
2022
Q3 | $778K | Buy |
2,405
+55
| +2% | +$17.8K | 0.21% | 80 |
|
|
2022
Q2 | $762K | Buy |
2,350
+69
| +3% | +$22.4K | 0.21% | 79 |
|
|
2022
Q1 | $653K | Buy |
2,281
+90
| +4% | +$25.8K | 0.16% | 89 |
|
|
2021
Q4 | $605K | Buy |
2,191
+1,105
| +102% | +$305K | 0.15% | 92 |
|
|
2021
Q3 | $161K | Sell |
1,086
-1,055
| -49% | -$156K | 0.12% | 95 |
|
|
2021
Q2 | $491K | Buy |
2,141
+245
| +13% | +$56.2K | 0.14% | 97 |
|
|
2021
Q1 | $354K | Buy |
1,896
+510
| +37% | +$95.2K | 0.13% | 94 |
|
|
2020
Q4 | $234K | Buy |
1,386
+300
| +28% | +$50.6K | 0.14% | 92 |
|
|
2020
Q3 | $161K | Sell |
1,086
-19
| -2% | -$2.82K | 0.12% | 95 |
|
|
2020
Q2 | $181K | Hold |
1,105
| – | – | 0.15% | 88 |
|
|
2020
Q1 | $153K | Sell |
1,105
-3,200
| -74% | -$443K | 0.16% | 84 |
|
|
2019
Q4 | $566K | Buy |
+4,305
| New | +$566K | 0.52% | 39 |
|